Post-MI Care, NSTEMI Revascularization, Afib Anticoagulation, and RSV Outcomes
Update: 2025-09-05
1
Description
Program notes:
0:53 Who needs a beta blocker after MI
1:53 Those with mild reduction of ejection fraction
2:53 Confined to those with 40-50% ejection fraction
3:15 Revascularization in NSTEMI
4:20 Composite outcome
5:20 Closes gap, do FFR
6:20 May not be physiologically significant
6:40 Is lifelong anticoagulation needed after ablation
7:41 Occurred less in those who stopped
8:30 RSV, cardiac events and hospitalizations
9:30 Lower hospitalization in those who got the vaccine
10:30 Acute respiratory illness hospitalization
11:30 Less benefit with existing CVD or immunocompromise
12:15 Several RSV vaccines
13:16 End
Comments
In Channel




